Painteq
Device Pain Management
PDI 00190776149833
General payments
$1,717,738
Research payments
$574,166
Through program year 2025, $1,717,738 in general payments and $574,166 in research payments were reported against Painteq (Pain Management).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $53,439 | 277 |
| 2025 | Research | $41,743 | 3 |
| 2024 | General | $367,797 | 4,787 |
| 2024 | Research | $24,187 | 4 |
| 2023 | General | $526,944 | 3,744 |
| 2023 | Research | $18,236 | 14 |
| 2022 | General | $536,224 | 3,094 |
| 2022 | Research | $229,083 | 74 |
| 2021 | General | $233,335 | 1,678 |
| 2021 | Research | $260,917 | 110 |
Breakdown
The top 5 of 38 recipients; each share is of general payments naming this product in 2025.
The top 5 of 13 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 17 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
13,580 general · 205 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.